Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative therapies to enhance cancer treatment outcomes globally. Headquartered in Los Angeles, California, the company leverages advanced therapeutics and a robust pipeline, primarily focusing on precision medicine to target specific cancer types. With a commitment to addressing unmet medical needs in oncology, Puma is poised to play a significant role in the evolving landscape of cancer care through its proprietary drug candidates.